Skip to main content

Main menu

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • Subject Collections
    • JASN Podcasts
    • Archives
    • Saved Searches
    • ASN Meeting Abstracts
  • Authors
    • Submit a Manuscript
    • Author Resources
  • Editorial Team
  • Subscriptions
  • More
    • About JASN
    • Alerts
    • Advertising
    • Editorial Fellowship Program
    • Feedback
    • Reprints
    • Impact Factor
  • ASN Kidney News
  • Other
    • CJASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
American Society of Nephrology
  • Other
    • CJASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Advertisement
American Society of Nephrology

Advanced Search

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • Subject Collections
    • JASN Podcasts
    • Archives
    • Saved Searches
    • ASN Meeting Abstracts
  • Authors
    • Submit a Manuscript
    • Author Resources
  • Editorial Team
  • Subscriptions
  • More
    • About JASN
    • Alerts
    • Advertising
    • Editorial Fellowship Program
    • Feedback
    • Reprints
    • Impact Factor
  • ASN Kidney News
  • Follow JASN on Twitter
  • Visit ASN on Facebook
  • Follow JASN on RSS
  • Community Forum
CLINICAL RESEARCH
You have accessRestricted Access

Angiomyeloproliferative Lesions Following Autologous Stem Cell Therapy

Duangpen Thirabanjasak, Kavirach Tantiwongse and Paul Scott Thorner
JASN July 2010, 21 (7) 1218-1222; DOI: https://doi.org/10.1681/ASN.2009111156
Duangpen Thirabanjasak
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kavirach Tantiwongse
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul Scott Thorner
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data Supps
  • Info & Metrics
  • View PDF
Loading

Article Figures & Data

Figures

  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1.

    Macroscopic appearance of resected kidney. A solid hemorrhagic mass is present in the renal sinus, external to which is atrophic renal parenchyma. In addition, three similar smaller lesions are present (arrows), separate from the main lesion.

  • Figure 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2.

    Microscopic appearance of lesion. (A) The lesion is composed of numerous vascular channels, containing red cells and mixtures of hematopoietic cells. (B) The vascular component of the lesion consists of channels of varying caliber lined by benign-appearing endothelial cells. (C) and (D) The hematopoietic cells are mainly erythroid precursors with a smaller number of myeloid and megakaryocytic precursors mixed with numerous macrophages (larger foamy cells). (Hematoxylin and eosin; magnification: ×200 in A; ×600 in B through D.)

  • Figure 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 3.

    Immunohistochemical profile of endothelial cells. Endothelial cells express (A) CD31, (B) VEGF receptor 1/Flt-1, and (C) VEGF receptor 2/Flk-1. (Immunoperoxidase; magnification: ×600 in A through C.)

  • Figure 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 4.

    Immunohistochemical panel of hematopoietic cells. (A) There is widespread expression of CD44, marking the erythroid precursors but not megakaryocytic cells. (B) Virtually 100% of hematopoietic cells were cycling as demonstrated by MIB1 expression, whereas endothelial cells were not cycling. (C) CD68 staining highlights the large number of macrophages present both in vascular channels and in the intervening stroma. (Immunoperoxidase; magnification: ×600 in A and B; ×200 in C.)

PreviousNext
Back to top

In this issue

Journal of the American Society of Nephrology: 21 (7)
Journal of the American Society of Nephrology
Vol. 21, Issue 7
1 Jul 2010
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
View Selected Citations (0)
Print
Download PDF
Sign up for Alerts
Email Article
Thank you for your help in sharing the high-quality science in JASN.
Enter multiple addresses on separate lines or separate them with commas.
Angiomyeloproliferative Lesions Following Autologous Stem Cell Therapy
(Your Name) has sent you a message from American Society of Nephrology
(Your Name) thought you would like to see the American Society of Nephrology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Angiomyeloproliferative Lesions Following Autologous Stem Cell Therapy
Duangpen Thirabanjasak, Kavirach Tantiwongse, Paul Scott Thorner
JASN Jul 2010, 21 (7) 1218-1222; DOI: 10.1681/ASN.2009111156

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Request Permissions
Share
Angiomyeloproliferative Lesions Following Autologous Stem Cell Therapy
Duangpen Thirabanjasak, Kavirach Tantiwongse, Paul Scott Thorner
JASN Jul 2010, 21 (7) 1218-1222; DOI: 10.1681/ASN.2009111156
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Abstract
    • Disclosures
    • Footnotes
    • REFERENCES
  • Figures & Data Supps
  • Info & Metrics
  • View PDF

More in this TOC Section

  • In Patients with Membranous Lupus Nephritis, Exostosin-Positivity and Exostosin-Negativity Represent Two Different Phenotypes
  • Risks of AKI and Major Adverse Clinical Outcomes in Patients with Severe Acute Respiratory Syndrome or Coronavirus Disease 2019
  • Missing Self-Induced Activation of NK Cells Combines with Non-Complement-Fixing Donor-Specific Antibodies to Accelerate Kidney Transplant Loss in Chronic Antibody-Mediated Rejection
Show more Clinical Research

Cited By...

  • Stem Cell Therapy for Knee Pain--What Exactly Are We Injecting, and Why?
  • From Patient to Dish and Back Again: Are We There Yet?
  • U.S. Regulation of Stem Cells as Medical Products
  • Stem cell tourism and Canadian family physicians
  • Le tourisme des cellules souches et les medecins de famille canadiens
  • Induced Pluripotent Stem Cells from Human Kidney
  • Cells for Treating Organ Damage: How Long Will We Need Them?
  • Stem Cell Therapy for the Kidney: A Cautionary Tale
  • Google Scholar

Similar Articles

Related Articles

  • Stem Cell Therapy for the Kidney: A Cautionary Tale
  • PubMed
  • Google Scholar

Articles

  • Current Issue
  • Early Access
  • Subject Collections
  • Article Archive
  • ASN Annual Meeting Abstracts

Information for Authors

  • Submit a Manuscript
  • Author Resources
  • Editorial Fellowship Program
  • ASN Journal Policies
  • Reuse/Reprint Policy

About

  • JASN
  • ASN
  • ASN Journals
  • ASN Kidney News

Journal Information

  • About JASN
  • JASN Email Alerts
  • JASN Key Impact Information
  • JASN Podcasts
  • JASN RSS Feeds
  • Editorial Board

More Information

  • Advertise
  • ASN Podcasts
  • ASN Publications
  • Become an ASN Member
  • Feedback
  • Follow on Twitter
  • Password/Email Address Changes
  • Subscribe

© 2021 American Society of Nephrology

Print ISSN - 1046-6673 Online ISSN - 1533-3450

Powered by HighWire